Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study. Akbas S, Alan O, Yildiz O, Karakurt M, et al. J Neurooncol 2026;176:152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Akbas S, Alan O, Yildiz O, Karakurt M, et al. Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study. J Neurooncol 2026;176:152.
PMID: 41492105